Inclusion Criteria:  Patients age 60 years or older with a confirmed diagnosis of multiple myeloma currently undergoing or planned to begin treatment for multiple myeloma. Enrollment in an existing registry of individuals with plasma cell disorder (ClinicalTrials.gov identifier NCT03717844; institutional protocol # LCCC1728) Be willing and capable of providing informed consent.  Presence of at least one intervenable deficit on the most recent registry assessment:  Activities of daily living score < 14. Instrumental activities of living score < 14. Timed Up and Go test = 14 seconds (or unable to complete the test). One fall in the prior 6 months. Eyesight poor or worse. Hearing poor or worse. Number of daily medications 10 or greater. Mental Health Index-13 Depression score 12 or greater. Mental Health Index-13 Anxiety score 6 or greater.  Exclusion Criteria:  Has dementia, altered mental status, or any psychiatric or co-morbid condition prohibiting the understanding or rendering of informed consent.